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Abstract
Background: The purpose of the current study was to examine the effect of a non-invasive, home-based
biomechanical treatment program for patients with spontaneous osteonecrosis of the knee (SONK).
Methods: Seventeen patients with SONK, confirmed by MRI, participated in this retrospective analysis. Patients
underwent a spatiotemporal gait analysis and completed the Western Ontario and McMaster University Osteoarthritis
Index (WOMAC) and the Short-Form-36 (SF-36). Following an initial assessment, patients commenced the
biomechanical treatment (AposTherapy). All patients were reassessed after 3 and 6 months of treatment.
Results: A significant reduction in pain and improvement in function was seen after 3 months of therapy with
additional improvement after 6 months of therapy. Pain was reduced by 53% and functional limitation reduced
by 43%. Furthermore, a significant improvement was also found in the SF-36 subscales, including the summary
of physical and mental scores. Significant improvements were found in most of the gait parameters including a
41% increase in gait velocity and a 22% increase in step length. Patients also demonstrated improvement in
limb symmetry, especially by increasing the single limb support of the involved limb.
Conclusions: Applying this therapy allowed patients to be active, while walking more symmetrically and with
less pain. With time, the natural course of the disease alongside the activity of the patients with the unique
biomechanical device led to a significant reduction in pain and improved gait patterns. Therefore, we believe
AposTherapy should be considered as a treatment option for patients with SONK.
Trial registration: Assaf Harofeh Medical Center Institutional Helsinki Committee Registry, 141/08; ClinicalTrials.
gov NCT00767780.
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Background
The knee, after the hip, is the second most common site
for osteonecrosis (ON) [1]. Spontaneous osteonecrosis
of the knee (SONK), first described by Ahlback et al. [2]
in 1968, is considered to be the most common form of
ON, with an incidence of 3.4 and 9.4% in persons older
than 50 and 65 years of age, respectively [3]. However,
the actual prevalence may be underestimated since many
patients with end-stage osteoarthritis (OA) may have
had an undiagnosed occult condition [4].
SONK is classically described as a focal, superficial
subchondral lesion, affecting the medial femoral condyle
in up to 94% of the time [5, 6]. The presenting symptom
is usually an acute onset of pain over the medial side of
the knee [7]. Focal tenderness over the medial femoral
condyle is the most common finding on physical
examination [8]. Patients often present deteriorated,
asymmetrical gait patterns [9] and complain that the
pain is worse during weight-bearing and at night [4].
The etiology of SONK remains unclear. Historically, it
was thought to occur secondary to ischemia, which
results in necrosis [2, 10]. However, recent evidence has
demonstrated that it may be due to subchondral
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insufficiency fractures in osteopenic bone with no evidence
of necrosis [5].
Non-operative management of SONK includes treatment
with non-steroidal anti-inflammatory drugs (NSAIDs),
protected weight-bearing, analgesics, high-dose of vita-
min D supplementation, and bisphosphonate [11]. Surgi-
cal management includes joint-preserving techniques
such as arthroscopic debridement and core decompres-
sion [12–14]. In end-stage SONK, uni-compartmental
knee arthroplasty or total knee arthroplasty are the most
common treatment options [15, 16]. Surprisingly, al-
though SONK is a fairly common, severely disabling,
and frequently deteriorating condition, there is only a
paucity of studies describing the different treatment
alternatives and no randomized or high-quality studies
comparing different treatment options have been de-
scribed [7, 11, 17–19].
In the last half decade, several publications have de-
scribed the effect of treatment with a unique non-invasive,
home-based biomechanical therapy on clinical symptoms
and gait patterns of patients with different musculoskeletal
conditions including knee pathologies, such as knee OA
[20–22], degenerative meniscal tear [23], and anterior
knee pain [24]. The aim of the current study was to exam-
ine the effect of this non-invasive biomechanical treat-




This was a retrospective analysis based on a private
clinic’s database. The protocol of the current study was
similar to previous publications of our research group
[23, 24], hence the similarity in the research method-
ology. However, for the first time, this research work
focused on patients with SONK. The protocol was
approved by Assaf Harofeh Medical Center Institutional
Helsinki Committee Registry (Helsinki registration num-
ber 141/08, NIH protocol no. NCT00767780). Since this
was a retrospective study, the ethics committee waived
the need for individual consent forms.
A search for eligible patients diagnosed with SONK
and confirmed by MRI was done on the clinic’s database
from January 2010 to August 2015. Inclusion criteria for
the study were SONK confirmed by MRI and having gait
data and questionnaires at pre-treatment assessment and
after 3 and 6 months of therapy. Exclusion criteria in-
cluded a history of major trauma, predisposing factors of
osteonecrosis, previous surgery to the knee excluding
arthroscopy, and knee arthroscopy in the 3 months prior
to the first assessment. Eighty-seven patients diagnosed
with SONK commenced therapy during the abovemen-
tioned period. Seventy patients were excluded since they
did not meet the inclusion criteria and/or had one or
more of the exclusion criteria. A total of 17 patients
were included in the analysis; their characteristics are
presented in Table 1.
Assessments
All patients underwent a spatiotemporal gait assessment
and completed clinical questionnaires to assess pain,
function, and quality of life at pre-treatment assessment
and following 3 and 6 months of therapy.
Anamnesis. During their first visit to the therapy cen-
ter, patients underwent systematic assessment including
a physical examination by a certified physical therapist
and anthropometric measurements of height and weight.
Spatiotemporal gait assessment. Using a computerized
mat (GaitMat system, E.Q., Inc. Chalfont, PA) [25],
patients were asked to walk barefoot at a self-selected
speed. Patients walked 3 m before and after the walkway
mat to allow sufficient acceleration and deceleration
time outside the measurement area. Four trials were
conducted, and acquired data were stored for further
analysis. The mean value of the four trials was calculated
for each of the following parameters: velocity (cm/s),
step length (cm), cadence (steps/min), base of support
(BOS) (cm), swing (% gait cycle (GC)), stance (% GC),
single limb support (% GC) (SLS), and double limb sup-
port (% GC) (DLS). Where applicable, results are pre-
sented for the involved limb and the uninvolved limb.
Clinical outcomes. Patients completed the Western
Ontario and McMaster Osteoarthritis Index (WOMAC)
to assess pain and function. This questionnaire contains
24 questions using a visual analogue scale (VAS). Results
may range from 0 to 100 mm, with 0 mm indicating no
pain, stiffness, or limitation in function and 100 mm in-
dicating the most severe pain, stiffness, or limitation in
function. The mean average of the 24 questions creates an
overall score. In addition, three subscales are calculated:
5 questions to assess pain, 2 questions to assess joint
stiffness, and 17 questions to assess function.
Patients also completed the Short-Form (SF)-36 Health
Survey to assess the quality of life (QoL). This question-
naire contains 36 Likert scale questions regarding different
aspects of QoL. The SF-36 is scored between 0 and 100,
with 0 indicating the worst quality of life and 100 indicat-
ing the best quality of life. An overall score is calculated
from the results of all questions. Furthermore, eight
Table 1 Patients’ characteristics
Mean (SD) Range
Male/female (%) 7/10 (41/59)
Age (years) 65.2 (9.7) 41–85
Weight (kg) 83.1 (13.0) 58–105
Height (cm) 162.6 (11.3) 142–183
Duration of symptoms (months) 6.2 (5.5) 1–24
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subscales can also be calculated including physical func-
tioning, pain, limitation due to physical health, vitality,
emotional well-being, limitation due to mental health,
social functioning, and general health. Two summarizing
scores are also available: a physical component summary
(PCS) which is the average score of the following four
categories: physical functioning, pain, limitation due to
physical health, and general health; and a mental compo-
nent summary (MCS) which is the average score of the
following four categories: vitality, emotional well-being,
limitation due to mental health, and social functioning.
Intervention
The biomechanical device (Apos System, Apos–Medical
and Sports Technologies Ltd. Herzliya, Israel) utilized
in the study and the treatment modality have been pre-
viously described [20, 22, 26, 27]. In brief, the device
consists of two convex-shaped biomechanical elements
attached to each foot using a platform in the form of a
shoe, allowing customized calibration (Fig. 1). By shift-
ing the biomechanical elements in the coronal and sa-
gittal planes, the device can be individually calibrated
to shift the trajectory of the foot’s center of pressure
during gait, thereby altering the orientation of the
ground reaction force vector. This enables a decrease in
the pressure load from the affected area in the joint
during gait [28–34]. The convex form of the biome-
chanical elements generates perturbations applied
throughout the stance phase of the gait cycle [35],
enabling dynamic, functional, and repetitive training
intended to improve neuromuscular control. Following
enrolment, the biomechanical device was individually
calibrated to each patient by a licensed physical therap-
ist specialized in AposTherapy methodology. Treatment
was then initiated and continued on a daily basis for a
period of 6 months. Patients were instructed to wear
the biomechanical device for 10 min once a day during
the first week, while performing daily routine (accumu-
lating 5 min of walk). Patients were instructed to grad-
ually increase walking time reaching 60 min once a day
(accumulating 30 min of walk).
Statistical analysis
All spatiotemporal gait parameters and self-evaluation
questionnaires scores were presented as mean and stand-
ard deviation, followed by 95% confidence interval for all
time periods. Non-parametric one-sample Kolmogorov-
Smirnov tests were calculated to compare the observed
cumulative distribution function for the continuous
variables with the normal theoretical distribution. The
GLM Repeated Measures procedures and Friedman
non-parametric tests were used to provide level of im-
provement for gait parameters and self-evaluation
questionnaires when the same measurement was made
three times on each subject.
The comparison between the involved and uninvolved
limb was conducted where applicable using paired t tests.
The correlations between the changes in gait velocity
(from pre-treatment assessment to 6 months’ follow-up)
and the changes in pain and function (from pre-treatment
assessment to 6 months’ follow-up) were assessed using
Spearman correlations.
Data were analyzed with IBM SPSS software version
23.0, and the significant level was set at 0.05.
Results
All patients complied with the treatment and completed
the study protocol with no adverse events reported.
Fig. 1 AposSystem. Biomechanical device
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Significant improvement was found in all gait measures
except for the base of support, stance phase of the in-
volved limb, swing phase of the involved limb, and SLS
phase of the uninvolved limb (Table 2). Furthermore, a
comparison between the involved and uninvolved limb
was also conducted where applicable. At pre-treatment
assessment, significant differences were found between
the involved and uninvolved limb in the following pa-
rameters: swing (p < 0.001), stance (p < 0.001), and SLS
(p < 0.001). After 3 months of treatment, significant dif-
ferences between limbs were found in swing (p = 0.028),
stance (p = 0.028), and SLS (p = 0.009). After 6 months
of treatment, significant differences between limbs were
found in swing (p = 0.011), stance (p = 0.011), and SLS
(p = 0.009).
Significant improvements were also found in the clin-
ical outcomes of pain, function, and QoL. Changes in
WOMAC subscales are presented in Fig. 2. Alongside
the statistical significance, patients also met the
OMERACT-OARSI clinical criteria for clinical signifi-
cance [36]. Changes in SF-36 overall score, subscales,
and PCS and MCS are presented in Table 3. Patients
met the minimal clinical important difference (MCID)
for rehabilitation intervention for patients with osteo-
arthritis of the lower extremity [37].
The correlations between the changes in gait velocity
(from pre-treatment assessment to 6 months’ follow-up)
and the changes in pain and function (from pre-treatment
assessment to 6 months’ follow-up) were calculated. A
significant moderate correlation was found between
the changes in gait velocity and the changes in pain
(r = −0.535, p = 0.027). The correlation between changes
in gait velocity and changes in function was −0.553
(p = 0.021).
Discussion
The purpose of the current study was to examine the ef-
fect of this non-invasive biomechanical treatment on gait
patterns and clinical symptoms of patients with SONK.
Following 6 months of treatment, a significant improve-
ment in gait pattern and quality of life and a significant
reduction in pain was noted.
The knee is a weight-bearing joint which contends
with massive loads during locomotion. Previous studies
have shown that gait patterns are compromised as a re-
sult of different musculoskeletal conditions in general
and specifically in knee conditions [38–41]. A recent
study showed that patients with SONK present altered
gait patterns compared to healthy individuals [9]. These
alterations may be due to a new gait strategy adopted by
Table 2 Changes in spatiotemporal gait following 6 months of treatment. Results are presented as mean (SD) [95% confidence interval, CI]
Pre-treatment 3 months 6 months P for GLM test P for Friedman test






P < 0.001 P < 0.001






P < 0.001 P < 0.001






P = 0.104 P = 0.257






P < 0.001 P < 0.001






P < 0.001 P < 0.001






P = 0.875 P = 0.101






P < 0.001 P < 0.001






P = 0.875 P = 0.101






P < 0.001 P < 0.001






P < 0.001 P < 0.001






P = 0.858 P = 0.589






P < 0.001 P < 0.001






P < 0.001 P < 0.001
GC gait cycle, SLS single limb support, DLS double limb support
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the patients in order to avoid joint loading and pain.
Furthermore, a major deviation in gait patterns of patients
with SONK is asymmetry in selected gait parameters in-
cluding single limb support, which reflects the ability of
the patient to bear loads on one limb while the contralat-
eral limb swings forward. This ability decreases dramatic-
ally in the involved limb and marked asymmetry is
present in patients with SONK. This is a decisive factor
since biomechanical asymmetries may have long-term
consequences, providing further support for the potential
role of loading on the onset and progression of knee
osteoarthritis [42]. The results of the current study show
that after 3 months of treatment with a unique biomech-
anical device, there was a significant improvement in gait
which continued to improve after 6 months. Patients
presented an overall increase of 41% in gait velocity, 22%
in step length, and 19% in cadence. The improvement in
velocity is crucial as it has been linked to survival in older
adults [43]. Patients also improved their ability to bear
loads on the affected limb, reflecting limb symmetry.
Although significant differences between limbs in SLS
were still present at 6 months, there was a substantial re-
duction in limb asymmetry. It may be assumed that
should this study have continued with a longer follow-up,
an additional improvement including the elimination of
significant asymmetry would have been found. We believe
that this therapy allowed patients to walk the extra mile,
mainly by enabling them to be active while implementing
less compensations by walking more symmetrically.
Although gait is an objective tool to assess the func-
tional condition of patients and results can be compared
between patients, it is also important to assess the clin-
ical changes over time with regard to pain, function, and
QoL. There was a moderate correlation between the im-
provement in gait velocity and the improvement in pain
and function. Patients were assessed using gold standard
questionnaires and reported a significant improvement
in pain (53%), function (43%), PCS (44%), and MCS
(28%), meeting the criteria for clinical significance
[36, 37]. Furthermore, the effect size of the change was
calculated and was found to be high for pain and func-
tion and medium for PCS and MCS [44, 45]. Effect
sizes for pain, function, PCS, and MCS were 1.05, 0.92,
0.70, and 0.60, respectively.
Fig. 2 Changes in WOMAC subscales following 6 months
of treatment
Table 3 Changes in SF-36 subscales following 6 months of treatment. Results are presented as mean (SD) [95 % confidence interval, CI]
Pre-treatment 3 months 6 months P for GLM test P for Friedman test
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P = 0.026 P = 0.028
PCS physical component summary, MCS mental component summary
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To the best of our knowledge, this is the first time a
non-pharmacological, non-invasive treatment is offered
to patients with SONK. This treatment is based on walk-
ing with a biomechanical device and allows patients to
be active. The unique structure of the device, which can
change the center of pressure and thereby change the
loads at the knee joint, enables patients to walk with re-
duced pain while improving neuromuscular control. The
current study showed positive results for patients with
SONK, adding support to the positive effect of treatment
for other knee conditions including degenerative menis-
cal tear [23], ACL tear [46], and anterior knee pain [24].
Some limitations should be acknowledged. First, this
was a single cohort study with no control group. The
lack of a control group makes it difficult to conclude
that the treatment is better than other alternatives. How-
ever, this study presents a positive trend and should be
considered as an additional non-invasive treatment
option for patients with SONK. It should be emphasized
that none of the patients required any surgical interven-
tion during the follow-up period. We acknowledge that
further research is necessary and recommend that a
future study should examine the effect of treatment for
patients with SONK in a randomized controlled trial.
This will support the preliminary results of the current
study. Second, this was a retrospective analysis of pa-
tients seeking treatment at a private clinic. As such, the
study population may have been biased to those who
were exposed to this clinic rather than the entire popula-
tion. We postulate that this had a minor effect on the
results and that the group’s characteristics are good
representatives of the population. Third, this study mon-
itored the changes in objective gait patterns and clinical
outcomes. Having a randomized controlled trial with an
additional MRI assessment of the involved knee after
6 months would have given a clearer picture of the
changes in the knee joint over time.
Conclusions
Following 6 months of therapy, patients presented a
significant improvement in gait and gained a more
symmetrical gait pattern. Patients also reported a sig-
nificant reduction in pain and improvement in function
and QoL, meeting the gold standard criteria for clinical
significance.
Abbreviations
BOS: Base of support; DLS: Double limb support; GC: Gait cycle; MCS: Mental
component summary; NSAIDs: Non-steroidal anti-inflammatory drugs;
OA: Osteoarthritis; ON: Osteonecrosis; PCS: Physical component summary;
QoL: Quality of life; SF: Short-Form; SLS: Single limb support; SONK:
Spontaneous osteonecrosis of the knee; VAS: Visual analogue scale;
WOMAC: Western Ontario and McMaster Osteoarthritis Index
Acknowledgements
The authors would like to thank Nira Koren-Morag Ph.D., biostatistician, for her
support in the statistical analysis.
Funding
This study was not funded in any way.
Availability of data and materials
The datasets during and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
All authors take full responsibility of the work presented and made substantial
contributions to this research work including: (1) the conception and design
of the study, or acquisition of data, or analysis and interpretation of data, (2)
drafting the article or revising it critically for important intellectual content,
and (3) final approval of the version to be submitted.
Competing interests
RD, AM, and AE hold shares in AposTherapy.
GS is a salaried employee of AposTherapy.
EA, DG, YB, NR, and YB are co-researchers in a number of studies. They do not
receive and are not entitled to any financial compensation from AposTherapy.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The protocol was approved by the Institutional Helsinki Committee Registry
(Helsinki registration number 141/08, NIH protocol no. NCT00767780). Since
this was a retrospective study, the ethics committee waived the need for
individual consent forms.
Author details
1Department of Orthopedic Surgery, Barzilai Medical Center, Ashkelon, Israel.
2AposTherapy Research Group, 1 Abba Even Blvd., 46733 Herzliya, Israel.
3Department of Orthopedic Surgery, HaEmek Medical Center, Afula, Israel.
4Department of Orthopedic Surgery, Assaf Harofeh Medical Center, Zerifin,
Israel.
Received: 14 September 2016 Accepted: 29 October 2016
References
1. Mont MA, Baumgarten KM, Rifai A, Bluemke DA, Jones LC, Hungerford DS.
Atraumatic osteonecrosis of the knee. J Bone Joint Surg Am. 2000;82(9):1279–90.
2. Ahlback S, Bauer GC, Bohne WH. Spontaneous osteonecrosis of the knee.
Arthritis Rheum. 1968;11(6):705–33.
3. Pape D, Seil R, Fritsch E, Rupp S, Kohn D. Prevalence of spontaneous
osteonecrosis of the medial femoral condyle in elderly patients. Knee Surg
Sports Traumatol Arthrosc. 2002;10(4):233–40.
4. Mont MA, Marker DR, Zywiel MG, Carrino JA. Osteonecrosis of the knee and
related conditions. J Am Acad Orthop Surg. 2011;19(8):482–94.
5. Yamamoto T, Bullough PG. Spontaneous osteonecrosis of the knee: the result
of subchondral insufficiency fracture. J Bone Joint Surg Am. 2000;82(6):858–66.
6. al-Rowaih A, Bjorkengren A, Egund N, Lindstrand A, Wingstrand H,
Thorngren KG. Size of osteonecrosis of the knee. Clin Orthop Relat Res.
1993;287:68–75.
7. Karim AR, Cherian JJ, Jauregui JJ, Pierce T, Mont MA. Osteonecrosis of the
knee: review. Ann Transl Med. 2015;3(1):6.
8. Houpt JB, Pritzker KP, Alpert B, Greyson ND, Gross AE. Natural history of
spontaneous osteonecrosis of the knee (SONK): a review. Semin Arthritis
Rheum. 1983;13(2):212–27.
9. Atoun E, Segal G, Debi R, Lubovsky O, Djabbarov R, Peskin B, et al. Gait
assessment of patients with spontaneous osteonecrosis of the knee.
Osteoarthritis and Cartilage. 2016;24(Supplement 1):1.
10. Aglietti P, Insall JN, Buzzi R, Deschamps G. Idiopathic osteonecrosis of
the knee. Aetiology, prognosis and treatment. J Bone Joint Surg Br.
1983;65(5):588–97.
11. Jureus J, Lindstrand A, Geijer M, Robertsson O, Tagil M. The natural course
of spontaneous osteonecrosis of the knee (SPONK): a 1- to 27-year follow-up
of 40 patients. Acta Orthop. 2013;84(4):410–4.
12. Miller GK, Maylahn DJ, Drennan DB. The treatment of idiopathic osteonecrosis
of the medial femoral condyle with arthroscopic debridement. Arthroscopy.
1986;2(1):21–9.
Atoun et al. Journal of Orthopaedic Surgery and Research  (2016) 11:139 Page 6 of 7
13. Akgun I, Kesmezacar H, Ogut T, Kebudi A, Kanberoglu K. Arthroscopic
microfracture treatment for osteonecrosis of the knee. Arthroscopy.
2005;21(7):834–43.
14. Forst J, Forst R, Heller KD, Adam G. Spontaneous osteonecrosis of the
femoral condyle: causal treatment by early core decompression. Arch
Orthop Trauma Surg. 1998;117(1-2):18–22.
15. Heyse TJ, Khefacha A, Fuchs-Winkelmann S, Cartier P. UKA after spontaneous
osteonecrosis of the knee: a retrospective analysis. Arch Orthop Trauma Surg.
2011;131(5):613–7.
16. Myers TG, Cui Q, Kuskowski M, Mihalko WM, Saleh KJ. Outcomes of total
and unicompartmental knee arthroplasty for secondary and spontaneous
osteonecrosis of the knee. J Bone Joint Surg Am. 2006;88 Suppl 3:76–82.
17. Breer S, Oheim R, Krause M, Marshall RP, Amling M, Barvencik F. Spontaneous
osteonecrosis of the knee (SONK). Knee Surg Sports Traumatol Arthrosc.
2013;21(2):340–5.
18. Kraenzlin ME, Graf C, Meier C, Kraenzlin C, Friedrich NF. Possible beneficial
effect of bisphosphonates in osteonecrosis of the knee. Knee Surg Sports
Traumatol Arthrosc. 2010;18(12):1638–44.
19. Jureus J, Lindstrand A, Geijer M, Roberts D, Tagil M. Treatment of
spontaneous osteonecrosis of the knee (SPONK) by a bisphosphonate.
Acta Orthop. 2012;83(5):511–4.
20. Bar-Ziv Y, Beer Y, Ran Y, Benedict S, Halperin N. A treatment applying a
biomechanical device to the feet of patients with knee osteoarthritis results
in reduced pain and improved function: a prospective controlled study.
BMC Musculoskelet Disord. 2010;11:179.
21. Elbaz A, Mor A, Segal G, Debbi E, Haim A, Halperin N, et al. APOS therapy
improves clinical measurements and gait in patients with knee osteoarthritis.
Clin Biomech (Bristol, Avon). 2010;25(9):920–5.
22. Haim A, Rubin G, Rozen N, Goryachev Y, Wolf A. Reduction in knee adduction
moment via non-invasive biomechanical training: a longitudinal gait analysis
study. J Biomech. 2012;45(1):41–5.
23. Elbaz A, Beer Y, Rath E, Morag G, Segal G, Debbi EM, et al. A unique foot-
worn device for patients with degenerative meniscal tear. Knee Surg Sports
Traumatol Arthrosc. 2013;21(2):380–7.
24. Haim A, Segal G, Elbaz A, Mor A, Agar G, Bar-Ziv Y, et al. The outcome of a
novel biomechanical therapy for patients suffering from anterior knee pain.
Knee. 2013;20(6):595–9.
25. Barker S, Craik R, Freedman W, Herrmann N, Hillstrom H. Accuracy, reliability,
and validity of a spatiotemporal gait analysis system. Med Eng Phys.
2006;28(5):460–7.
26. Debbi EM, Wolf A, Goryachev Y, Rozen N, Haim A. Alterations in sagittal
plane knee kinetics in knee osteoarthritis using a biomechanical therapy
device. Ann Biomed Eng. 2015;43(5):1089–97.
27. Elbaz A, Mor A, Segal G, Aloni Y, Teo TH, Teo YS, et al. Patients with knee
osteoarthritis demonstrate improved gait pattern and reduced pain following
a non-invasive biomechanical therapy: a prospective multi-center study on
Singaporean population. J Orthop Surg Res. 2014;9:1–8.
28. Haim A, Rozen N, Dekel S, Halperin N, Wolf A. Control of knee coronal plane
moment via modulation of center of pressure: a prospective gait analysis
study. J Biomech. 2008;41(14):3010–6.
29. Haim A, Rozen N, Wolf A. The influence of sagittal center of pressure offset
on gait kinematics and kinetics. J Biomech. 2010;43(5):969–77.
30. Haim A, Wolf A, Rubin G, Genis Y, Khoury M, Rozen N. Effect of center of
pressure modulation on knee adduction moment in medial compartment
knee osteoarthritis. J Orthop Res. 2011;29(11):1668–74.
31. Khoury M, Wolf A, Debbi EM, Herman A, Haim A. Foot center of pressure
trajectory alteration by biomechanical manipulation of shoe design.
Foot Ankle Int. 2013;34(4):593–8.
32. Khoury M, Haim A, Herman A, Rozen N, Wolf A. Alteration of the foot center of
pressure trajectory by an unstable shoe design. J Foot Ankle Res. 2015;8:67.
33. Solomonow-Avnon D, Wolf A, Herman A, Rozen N, Haim A. Reduction of
frontal-plane hip joint reaction force via medio-lateral foot center of
pressure manipulation: a pilot study. J Orthop Res. 2015;33(2):261–9.
34. Solomonow-Avnon D, Haim A, Levin D, Elboim-Gabyzon M, Rozen N,
Peled E, et al. Reduction of hip joint reaction force via medio-lateral foot
center of pressure manipulation in bilateral hip osteoarthritis patients.
J Orthop Res. 2016.
35. Debbi EM, Wolf A, Haim A. Detecting and quantifying global instability
during a dynamic task using kinetic and kinematic gait parameters.
J Biomech. 2012;45(8):1366–71.
36. Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M,
et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International
set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis
Cartilage. 2004;12(5):389–99.
37. Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically
important differences of rehabilitation intervention with their implications for
required sample sizes using WOMAC and SF-36 quality of life measurement
instruments in patients with osteoarthritis of the lower extremities. Arthritis
Rheum. 2001;45(4):384–91.
38. Assa T, Elbaz A, Mor A, Chechik O, Morag G, Salai M, et al. Gait metric profile
of 157 patients suffering from anterior knee pain. A controlled study. Knee.
2013;20(1):40–4.
39. Elbaz A, Mor A, Segal O, Agar G, Halperin N, Haim A, et al. Can single limb
support objectively assess the functional severity of knee osteoarthritis?
Knee. 2012;19(1):32–5.
40. Gigi R, Haim A, Luger E, Segal G, Melamed E, Beer Y, et al. Deviations in
gait metrics in patients with chronic ankle instability: a case control study.
J Foot Ankle Res. 2015;8(1):1.
41. Khashan M, Mor A, Beer Y, Rath E, Morgensteren DR, Debi R, et al.
Gait metric profile and gender differences in hip osteoarthritis patients.
A case-controlled study. Hip Int. 2014;24(3):270–6.
42. Shakoor N, Dua A, Thorp LE, Mikolaitis RA, Wimmer MA, Foucher KC, et al.
Asymmetric loading and bone mineral density at the asymptomatic knees of
patients with unilateral hip osteoarthritis. Arthritis Rheum. 2011;63(12):3853–8.
43. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. Gait
speed and survival in older adults. JAMA. 2011;305(1):50–8.
44. Cohen J. A power primer. Psychol Bull. 1992;112(1):155–9.
45. Durlak JA. How to select, calculate, and interpret effect sizes. J Pediatr Psychol.
2009;34(9):917–28.
46. Elbaz A, Cohen M, Debbi E, Rath U, Mor A, Morag G, et al. A noninvasive
biomechanical treatment as an additional tool in the rehabilitation of an
acure anterio cruciate ligamnet tear: a case report. SAGE Open Medical
Case Report. 2014;2:6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Atoun et al. Journal of Orthopaedic Surgery and Research  (2016) 11:139 Page 7 of 7
